lobbying_activities: 3191294

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3191294	bf187fcc-4caf-4b4a-b855-aaa8fb8b98f9	Q2	AMERICAN VETERINARY MEDICAL ASSOCIATION	3630	AMERICAN VETERINARY MEDICAL ASSOCIATION	2024	second_quarter	PHA	H.R. 1839/S. 993 Combating Illicit Xylazine Act, all provisions H.R. 4531 Support for Patients and Communities Reauthorization Act, Section 203 S. 3393 SUPPORT for patients and Communities Reauthorization Act, review of language related to xylazine for potential inclusion S. Amendment #1916 to H.R. 3935 FAA Reauthorization Act of 2024, updated Combating Illicit Xylazine Act language	Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE		340000	0	0	2024-07-15T09:09:30-04:00